{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:28:49Z","timestamp":1791808129351,"version":"4.3.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100003189","name":"National Tay-Sachs and Allied Diseases Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003189","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1038\/s41591-025-03822-4","type":"journal-article","created":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T09:04:17Z","timestamp":1755248657000},"page":"2927-2935","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Dual-vector rAAVrh8 gene therapy for GM2 gangliosidosis: a phase 1\/2 trial"],"prefix":"10.1038","volume":"31","author":[{"given":"Florian","family":"Eichler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oguz I.","family":"Cataltepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rrita","family":"Daci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajit S.","family":"Puri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toloo","family":"Taghian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9048-7294","authenticated-orcid":false,"given":"Xuntian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3175-8098","authenticated-orcid":false,"given":"Mohammed Salman","family":"Shazeeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kuhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Hader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakki","family":"Celik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynep","family":"Vardar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8204-5848","authenticated-orcid":false,"given":"Connor J.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Artinian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8116-4805","authenticated-orcid":false,"given":"Amanda","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7462-1422","authenticated-orcid":false,"given":"Behroze","family":"Vachha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6381-6902","authenticated-orcid":false,"given":"Thomas","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scot","family":"Bateman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Parzych","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spiro G.","family":"Spanakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toby A.","family":"Vaughn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Pier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"De Boever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary-Alice","family":"Abbott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"D\u2032Ambrosio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Kokoski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan","family":"Blackwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Drummond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva-Maria","family":"Ratai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise L.","family":"Townsend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haley","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia J.","family":"Tifft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5202-4616","authenticated-orcid":false,"given":"Allison M.","family":"Keeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0854-0143","authenticated-orcid":false,"given":"Miguel","family":"Sena-Esteves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7856-3159","authenticated-orcid":false,"given":"Heather L.","family":"Gray-Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8255-0588","authenticated-orcid":false,"given":"Terence R.","family":"Flotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,15]]},"reference":[{"key":"3822_CR1","doi-asserted-by":"publisher","first-page":"e1233","DOI":"10.1542\/peds.2011-0078","volume":"128","author":"AE Bley","year":"2011","unstructured":"Bley, A. E. et al. Natural history of infantile GM2 gangliosidosis. Pediatrics 128, e1233\u2013e1241 (2011).","journal-title":"Pediatrics"},{"key":"3822_CR2","first-page":"663","volume":"13","author":"DS Regier","year":"2016","unstructured":"Regier, D. S., Proia, R. L., D\u2019Azzo, A. & Tifft, C. J. The GM1 and GM2 gangliosidoses: natural history and progress toward therapy. Pediatr. Endocrinol. Rev. 13, 663\u2013673 (2016).","journal-title":"Pediatr. Endocrinol. Rev."},{"key":"3822_CR3","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S1474-4422(21)00001-6","volume":"20","author":"JW Day","year":"2021","unstructured":"Day, J. W. et al. Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial. Lancet Neurol. 20, 284\u2013293 (2021).","journal-title":"Lancet Neurol."},{"key":"3822_CR4","doi-asserted-by":"publisher","first-page":"134ra61","DOI":"10.1126\/scitranslmed.3003640","volume":"4","author":"W-L Hwu","year":"2012","unstructured":"Hwu, W.-L. et al. Gene therapy for aromatic l-amino acid decarboxylase deficiency. Sci. Transl. Med. 4, 134ra61 (2012).","journal-title":"Sci. Transl. Med."},{"key":"3822_CR5","doi-asserted-by":"publisher","first-page":"4251","DOI":"10.1038\/s41467-021-24524-8","volume":"12","author":"TS Pearson","year":"2021","unstructured":"Pearson, T. S. et al. Gene therapy for aromatic L-amino acid decarboxylase deficiency by MR-guided direct delivery of AAV2-AADC to midbrain dopaminergic neurons. Nat. Commun. 12, 4251 (2021).","journal-title":"Nat. Commun."},{"key":"3822_CR6","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1038\/mt.2010.135","volume":"18","author":"S Muramatsu","year":"2010","unstructured":"Muramatsu, S. et al. A phase I study of aromatic L-amino acid decarboxylase gene therapy for Parkinson\u2019s disease. Mol. Ther. 18, 1731\u20131735 (2010).","journal-title":"Mol. Ther."},{"key":"3822_CR7","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1093\/brain\/awy331","volume":"142","author":"K Kojima","year":"2019","unstructured":"Kojima, K. et al. Gene therapy improves motor and mental function of aromatic l-amino acid decarboxylase deficiency. Brain 142, 322\u2013333 (2019).","journal-title":"Brain"},{"key":"3822_CR8","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ymthe.2021.11.005","volume":"30","author":"C-H Tai","year":"2022","unstructured":"Tai, C.-H. et al. Long-term efficacy and safety of eladocagene exuparvovec in patients with AADC deficiency. Mol. Ther. 30, 509\u2013518 (2022).","journal-title":"Mol. Ther."},{"key":"3822_CR9","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1089\/hum.2017.163","volume":"29","author":"HL Gray-Edwards","year":"2018","unstructured":"Gray-Edwards, H. L. et al. Adeno-associated virus gene therapy in a sheep model of Tay\u2013Sachs disease. Hum. Gene Ther. 29, 312\u2013326 (2018).","journal-title":"Hum. Gene Ther."},{"key":"3822_CR10","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.expneurol.2014.09.020","volume":"263","author":"AM Bradbury","year":"2015","unstructured":"Bradbury, A. M. et al. Biomarkers for disease progression and AAV therapeutic efficacy in feline Sandhoff disease. Exp. Neurol. 263, 102\u2013112 (2015).","journal-title":"Exp. Neurol."},{"key":"3822_CR11","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ymgme.2015.05.003","volume":"116","author":"HL Gray-Edwards","year":"2015","unstructured":"Gray-Edwards, H. L. et al. Mucopolysaccharidosis-like phenotype in feline Sandhoff disease and partial correction after AAV gene therapy. Mol. Genet. Metab. 116, 80\u201387 (2015).","journal-title":"Mol. Genet. Metab."},{"key":"3822_CR12","doi-asserted-by":"publisher","unstructured":"Flotte, T. R. & Keeler, A. M. Characterization of immune responses to rAAVrh8 gene therapy for GM2 gangliosidosis in phase 1\/2 trial. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2025.05.07.25327170 (2025).","DOI":"10.1101\/2025.05.07.25327170"},{"key":"3822_CR13","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/s41434-020-00190-1","volume":"28","author":"VJ McCurdy","year":"2021","unstructured":"McCurdy, V. J. et al. Therapeutic benefit after intracranial gene therapy delivered during the symptomatic stage in a feline model of Sandhoff disease. Gene Ther. 28, 142\u2013154 (2021).","journal-title":"Gene Ther."},{"key":"3822_CR14","doi-asserted-by":"publisher","first-page":"175909141556990","DOI":"10.1177\/1759091415569908","volume":"7","author":"HE Rockwell","year":"2015","unstructured":"Rockwell, H. E. et al. AAV-mediated gene delivery in a feline model of Sandhoff disease corrects lysosomal storage in the central nervous system. ASN Neuro. 7, 175909141556990 (2015).","journal-title":"ASN Neuro."},{"key":"3822_CR15","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/S0022-3476(64)80161-X","volume":"65","author":"L Schneck","year":"1964","unstructured":"Schneck, L., Maisel, J. & Volk, B. W. The startle response and serum enzyme profile in early detection of Tay\u2013Sachs\u2019 disease. J. Pediatr. 65, 749\u2013756 (1964).","journal-title":"J. Pediatr."},{"key":"3822_CR16","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41591-021-01664-4","volume":"28","author":"TR Flotte","year":"2022","unstructured":"Flotte, T. R. et al. AAV gene therapy for Tay\u2013Sachs disease. Nat. Med. 28, 251\u2013259 (2022).","journal-title":"Nat. Med."},{"key":"3822_CR17","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ymgme.2017.12.432","volume":"123","author":"I Nestrasil","year":"2018","unstructured":"Nestrasil, I. et al. Distinct progression patterns of brain disease in infantile and juvenile gangliosidoses: volumetric quantitative MRI study. Mol. Genet. Metab. 123, 97\u2013104 (2018).","journal-title":"Mol. Genet. Metab."},{"key":"3822_CR18","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ymgme.2017.04.011","volume":"121","author":"JR Jarnes Utz","year":"2017","unstructured":"Jarnes Utz, J. R. et al. Infantile gangliosidoses: mapping a timeline of clinical changes. Mol. Genet. Metab. 121, 170\u2013179 (2017).","journal-title":"Mol. Genet. Metab."},{"key":"3822_CR19","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1089\/hum.2024.173","volume":"35","author":"K Flynn","year":"2024","unstructured":"Flynn, K. & Jussila, D. Voice of the patient report on GM2 gangliosidosis (Tay\u2013Sachs and Sandhoff). Hum. Gene Ther. 35, 869\u2013881 (2024).","journal-title":"Hum. Gene Ther."},{"key":"3822_CR20","doi-asserted-by":"publisher","first-page":"136195","DOI":"10.1016\/j.neulet.2021.136195","volume":"764","author":"C Toro","year":"2021","unstructured":"Toro, C., Zainab, M. & Tifft, C. J. The GM2 gangliosidoses: unlocking the mysteries of pathogenesis and treatment. Neurosci. Lett. 764, 136195 (2021).","journal-title":"Neurosci. Lett."},{"key":"3822_CR21","doi-asserted-by":"publisher","first-page":"e1550","DOI":"10.1542\/peds.2006-0588","volume":"118","author":"GHB Maegawa","year":"2006","unstructured":"Maegawa, G. H. B. et al. The natural history of juvenile or subacute GM2 gangliosidosis: 21 new cases and literature review of 134 previously reported. Pediatrics 118, e1550\u2013e1562 (2006).","journal-title":"Pediatrics"},{"key":"3822_CR22","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/01.GIM.0000154300.84107.75","volume":"7","author":"O Neudorfer","year":"2005","unstructured":"Neudorfer, O. et al. Late-onset Tay\u2013Sachs disease: phenotypic characterization and genotypic correlations in 21 affected patients. Genet. Med. 7, 119\u2013123 (2005).","journal-title":"Genet. Med."},{"key":"3822_CR23","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","volume":"377","author":"JR Mendell","year":"2017","unstructured":"Mendell, J. R. et al. Single-dose gene-replacement therapy for spinal muscular atrophy. N. Engl. J. Med. 377, 1713\u20131722 (2017).","journal-title":"N. Engl. J. Med."},{"key":"3822_CR24","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.ymthe.2019.11.012","volume":"28","author":"T Taghian","year":"2020","unstructured":"Taghian, T. et al. A safe and reliable technique for CNS delivery of AAV vectors in the cisterna magna. Mol. Ther. 28, 411\u2013421 (2020).","journal-title":"Mol. Ther."},{"key":"3822_CR25","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1002\/ana.26756","volume":"94","author":"AK Johnson","year":"2023","unstructured":"Johnson, A. K. et al. Life\u2010limiting peripheral organ dysfunction in feline Sandhoff disease emerges after effective CNS gene therapy. Ann. Neurol. 94, 969\u2013986 (2023).","journal-title":"Ann. Neurol."},{"key":"3822_CR26","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.neuroscience.2016.10.047","volume":"340","author":"AM Bradbury","year":"2017","unstructured":"Bradbury, A. M. et al. AAV-mediated gene delivery attenuates neuroinflammation in feline Sandhoff disease. Neuroscience 340, 117\u2013125 (2017).","journal-title":"Neuroscience"},{"key":"3822_CR27","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/gt.2014.108","volume":"22","author":"VJ McCurdy","year":"2015","unstructured":"McCurdy, V. J. et al. Widespread correction of central nervous system disease after intracranial gene therapy in a feline model of Sandhoff disease. Gene Ther. 22, 181\u2013189 (2015).","journal-title":"Gene Ther."},{"key":"3822_CR28","doi-asserted-by":"publisher","first-page":"3632","DOI":"10.1016\/j.ymthe.2022.08.003","volume":"30","author":"MT Rocco","year":"2022","unstructured":"Rocco, M. T. et al. Long-term safety of MRI-guided administration of AAV2-GDNF and gadoteridol in the putamen of individuals with Parkinson\u2019s disease. Mol. Ther. 30, 3632\u20133638 (2022).","journal-title":"Mol. Ther."},{"key":"3822_CR29","first-page":"387","volume":"27","author":"S Moriwaki","year":"1977","unstructured":"Moriwaki, S. et al. Histological observation of the brain of Tay\u2013Sachs disease with seizure and chronic dph intoxication: report of an autopsy case. Acta Pathol. Jpn 27, 387\u2013407 (1977).","journal-title":"Acta Pathol. Jpn"},{"key":"3822_CR30","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1016\/j.ymthe.2020.06.021","volume":"28","author":"HG Lahey","year":"2020","unstructured":"Lahey, H. G. et al. Pronounced therapeutic benefit of a single bidirectional AAV vector administered systemically in Sandhoff mice. Mol. Ther. 28, 2150\u20132160 (2020).","journal-title":"Mol. Ther."},{"key":"3822_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2019.116131","volume":"202","author":"F-C Yeh","year":"2019","unstructured":"Yeh, F.-C. et al. Differential tractography as a track-based biomarker for neuronal injury. NeuroImage 202, 116131 (2019).","journal-title":"NeuroImage"},{"key":"3822_CR32","doi-asserted-by":"publisher","unstructured":"Lewis, C. J., et al. Differential tractography: a biomarker for neuronal function in neurodegenerative disease. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2024.08.25.24312255 (2024).","DOI":"10.1101\/2024.08.25.24312255"},{"key":"3822_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fnimg.2024.1410848","volume":"3","author":"C Zoppo","year":"2024","unstructured":"Zoppo, C. et al. Quantitative reliability assessment of brain MRI volumetric measurements in type II GM1 gangliosidosis patients. Front. Neuroimaging 3, 1410848 (2024).","journal-title":"Front. Neuroimaging"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03822-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03822-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03822-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T10:09:54Z","timestamp":1788516594000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03822-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,15]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["3822"],"URL":"https:\/\/doi.org\/10.1038\/s41591-025-03822-4","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,15]]},"assertion":[{"value":"20 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.S.-E. may be entitled to receive licensing revenue from the patents covering the technologies used in this study. The remaining authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}